Danaher had a disappointing 2024. The path to success next year lies on Wall Street
Life sciences company Danaher has certainly not been an easy stock to own this year. A wave of...
Read MoreAuthor: Times Reporter
FDA Zepbound shortage ends, impacts patients, compounding pharmacies
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec....
Read More
Digital healthcare stocks came under pressure on Wall Street in 2024, but Hims is booming
Doximity listed on the New York Stock Exchange for its initial public offering on June 24,...
Read More
My inner ego fueled my dreams in comedy and acting
Sasha Merci as Josefina in “La Egoísta” by Erlina Ortiz at the Philadelphia Theater Company....
Read More
Trump's 25 percent tariffs pose an existential threat to the Canadian auto industry
Canadian and American flags fly near the base of the Ambassador Bridge, which connects Canada to...
Read MoreRecent Posts
Our Authors
Recent Videos
